_version_ 1818129111357325312
author Saum Ghodoussipour
Amir Lebastchi
Peter Pinto
Andre Berger
author_facet Saum Ghodoussipour
Amir Lebastchi
Peter Pinto
Andre Berger
author_sort Saum Ghodoussipour
collection DOAJ
first_indexed 2024-12-11T07:43:57Z
format Article
id doaj.art-76f4cb095f7949eaa029002b77a6866a
institution Directory Open Access Journal
issn 1677-6119
language English
last_indexed 2024-12-11T07:43:57Z
publisher Sociedade Brasileira de Urologia
record_format Article
series International Brazilian Journal of Urology
spelling doaj.art-76f4cb095f7949eaa029002b77a6866a2022-12-22T01:15:30ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-611945221521910.1590/s1677-5538.ibju.2019.02.03S1677-55382019000200215Super active surveillance for low-risk prostate cancer | Opinion: NoSaum GhodoussipourAmir LebastchiPeter PintoAndre Bergerhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000200215&lng=en&tlng=enProstatic NeoplasmsRisk Reduction BehaviorWatchful WaitingTherapeutics
spellingShingle Saum Ghodoussipour
Amir Lebastchi
Peter Pinto
Andre Berger
Super active surveillance for low-risk prostate cancer | Opinion: No
International Brazilian Journal of Urology
Prostatic Neoplasms
Risk Reduction Behavior
Watchful Waiting
Therapeutics
title Super active surveillance for low-risk prostate cancer | Opinion: No
title_full Super active surveillance for low-risk prostate cancer | Opinion: No
title_fullStr Super active surveillance for low-risk prostate cancer | Opinion: No
title_full_unstemmed Super active surveillance for low-risk prostate cancer | Opinion: No
title_short Super active surveillance for low-risk prostate cancer | Opinion: No
title_sort super active surveillance for low risk prostate cancer opinion no
topic Prostatic Neoplasms
Risk Reduction Behavior
Watchful Waiting
Therapeutics
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000200215&lng=en&tlng=en
work_keys_str_mv AT saumghodoussipour superactivesurveillanceforlowriskprostatecanceropinionno
AT amirlebastchi superactivesurveillanceforlowriskprostatecanceropinionno
AT peterpinto superactivesurveillanceforlowriskprostatecanceropinionno
AT andreberger superactivesurveillanceforlowriskprostatecanceropinionno